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Abstract
Objective To evaluate the effectiveness and costs of a multifaceted
flexible educational programme aimed at reducing antibiotic dispensing
at the practice level in primary care.
Design Randomised controlled trial with general practices as the unit
of randomisation and analysis. Clinicians and researchers were blinded
to group allocation until after randomisation.
Setting 68 general practices with about 480 000 patients in Wales,
United Kingdom.
Participants 34 practices were randomised to receive the educational
programme and 34 practices to be controls. 139 clinicians from the
intervention practices and 124 from control practices had agreed to
participate before randomisation. Practice level data covering all the
clinicians in the 68 practices were analysed.
Interventions Intervention practices followed the Stemming the Tide of
Antibiotic Resistance (STAR) educational programme, which included
a practice based seminar reflecting on the practices’ own dispensing
and resistance data, online educational elements, and practising
consulting skills in routine care. Control practices provided usual care.
Main outcome measures Total numbers of oral antibiotic items
dispensed for all causes per 1000 practice patients in the year after the
intervention, adjusted for the previous year’s dispensing. Secondary
outcomes included reconsultations, admissions to hospital for selected
causes, and costs.
Results The rate of oral antibiotic dispensing (items per 1000 registered
patients) decreased by 14.1 in the intervention group but increased by
12.1 in the control group, a net difference of 26.1. After adjustment for
baseline dispensing rate, this amounted to a 4.2% (95% confidence
interval 0.6% to 7.7%) reduction in total oral antibiotic dispensing for the
year in the intervention group relative to the control group (P=0.02).
Reductions were found for all classes of antibiotics other than
penicillinase-resistant penicillins but were largest and significant
individually for phenoxymethylpenicillins (penicillin V) (7.3%, 0.4% to
13.7%) andmacrolides (7.7%, 1.1% to 13.8%). There were no significant
differences between intervention and control practices in the number of
admissions to hospital or in reconsultations for a respiratory tract infection
within seven days of an index consultation. The mean cost of the
programme was £2923 (€3491, $4572) per practice (SD £1187). There
was a 5.5% reduction in the cost of dispensed antibiotics in the
intervention group compared with the control group (−0.4% to 11.4%),
equivalent to a reduction of about £830 a year for an average intervention
practice.
Conclusion The STAR educational programme led to reductions in all
cause oral antibiotic dispensing over the subsequent year with no
significant change in admissions to hospital, reconsultations, or costs.
Trial registration ISRCT No 63355948.
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Introduction
Antibiotic resistance is one of the most important public health
issues of our time, and antibiotic use is an important factor in
the increase in resistance at the population and individual level.1 2
As most antibiotics are prescribed in primary care and many of
these prescriptions for conditions such as bronchitis, otitis media,
purulent rhinitis, and sinusitis are of questionable value, reducing
inappropriate prescribing in this setting is an important goal.3-7
Antibiotic use increases an individual’s risk of carrying and
being infected by resistant organisms rather than sensitive
organisms, with the greatest effect occurring immediately after
treatment but persisting for up to 12 months.2 8 In a systematic
review andmeta-analysis of five studies of urinary tract bacteria
that included 14 348 participants, the pooled odds ratio for
resistance was 2.5 (95% confidence interval 2.1 to 2.9) within
two months of antibiotic treatment and 1.3 (1.2 to 1.5) within
12 months. In seven studies of respiratory tract bacteria that
included 2605 participants, pooled odds ratios were 2.4 (1.4 to
3.9) and 2.4 (1.3 to 4.5) for the same periods.2 In addition to
driving resistance, inappropriate prescribing of antibiotics wastes
resources, unnecessarily exposes people to the risk of side
effects, and encourages future consulting.9 10 Antibiotic
resistance is common in primary care, causes symptoms to last
for longer,11 and is associated with higher drug and
reconsultation costs.12Conserving antibiotic sensitivity through
more appropriate use is a priority.13 Importantly, reducing
antibiotic prescribing has been associated with a reduction in
antimicrobial resistance.14-16
Although antibiotic prescribing to ambulatory patients decreased
by about a third in most developed countries during the 1990s,
the use of broad spectrum agents has increased in the United
States,17 and antibiotic prescribing has increased since 2000 in
primary care in the United Kingdom.18 19 For example, there
was a 10% increase in antibiotic prescribing for children
between 2003 and 2006.18 19
Recent public campaigns on antibiotic awareness in the UK
have not been associated with reductions in all cause antibiotic
prescribing in primary care.20 There is wide variation between
general practices in antibiotic prescribing rates that cannot be
explained by differences in the epidemiology of infections,
populations, or case mix.1 21 22 Further gains could therefore
safely bemade by reducing inappropriate antibiotic prescribing.9
Interventions are likely to be most effective if they are
multifaceted and broadly applicable across a range of infections
in all age groups, rather than focused on single strategies for
single conditions in single age groups (such as a guideline for
managing sore throat in children).23
Changing clinicians’ prescribing behaviour, however, is a
complex matter.24 Guidelines have limited effect, even when
clinicians have been involved in their development.25 26
Systematic reviews24 27-29 of interventions to change clinician
behaviour have found that successful interventions are most
likely to be multifaceted, based on an assessment of barriers to
change, responsive to local circumstances, and focused, and to
incorporate an active educational outreach component including
skills development and to resonate with clinicians’ values.30 31
Systematic reviews of interventions to enhance the quality of
antibiotic prescribing practices in ambulatory care have also
found that multifaceted interventions are likely to be most
effective.23 32 Blended learning interventions offer variety,
flexibility, and convenience and are increasingly promoted, but
their effectiveness in enhancing antibiotic prescribing has not
been assessed. Interventions that are informed by theories of
behaviour change are likely to be more effective.33 For example,
shared decision making with patients is being promoted and
achieves more conservative antibiotic prescribing in efficacy
studies.34-37 Reducing antibiotic prescribing in primary care,
however, should not be at the expense of increased
reconsultations, admission to hospital, or, ideally, costs.
We developed the Stemming the Tide of Antibiotic Resistance
(STAR) educational programme to be multifaceted (e-learning,
practice based outreach, experiential learning and reflections),
responsive to local circumstances (feedback of practice level
data on antibiotic dispensing and resistance), and based on
previously identified recommendations (practice-wide effort;
time efficient consultation strategies that “enable” patients and
maintain relationships).38-40 It used a phased engagement and
implementation process to achieve certification on completion
of a learning portfolio and then sought to maintain change
through a web based exchange of experiences.40Based on social
learning theory, the intervention attempted to develop clinicians’
sense of importance about change (the “why” of change) and
their confidence in their ability to achieve change (the “how”
of change).41 42 We determined whether the STAR programme
could reduce antibiotic dispensing for all causes at the practice
level in primary care without increasing reconsultations,
admissions to hospital for selected causes, and costs.
Methods
Setting
The study was conducted in general medical practices inWales,
UK, in 2007 and 2008 (see below). In the UK people, regardless
of age, are registered with a general practice and consult with
that practice for their primary care unless there are unusual
circumstances such as being away from home or direct
attendance at an emergency department, usually in the event of
an acute more serious illness. Registered patients constitute the
practices’ lists and these vary over time for each practice. Part
of general practitioners’ payments is determined by list sizes
so these data are generally kept up to date.
Study design
We randomised general practices to intervention or control
(usual care). As patients registered at a practice can be managed
by any of the clinicians in the practice, we considered the
practice as the unit for randomisation and analysis. The main
outcome measure was the rate of dispensing oral antibiotics for
any cause over one year for the whole practice population.
Clinicians provided consent to participate, but consent from
individual patients was not required. The details of the trial
design have already been published.43
Randomisation and blinding
Randomisation took place once all practices were recruited and
all participating clinicians had provided written consent. This
allowed us to use dynamic block allocation44 45 to achieve
balance between groups of practices for the potential
confounders of previous rate of antibiotic dispensing (averaged
over the past year), practice size (number of whole time
equivalent staff at recruitment), and proportion of clinicians in
the practice registered for the study. The practices were divided
into three sets of 24, 22, and 22 practices; within each set we
generated all possible allocations into two groups and selected
the 1000 allocations within each set with the best balance with
respect to the specified confounders. The independent statistician
on the trial steering committee selected one allocation at random
for each set and randomly assigned intervention or control to
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the two groups in each set to construct the final allocation. Thus,
all were blinded to group allocation until after randomisation.
Intervention
This intervention was a blended learning experience for
participants as it was a combination of various learning methods
and topics (reflection on own practice, provision of new research
evidence and guidelines, video-rich material presenting novel
communication skills based on motivational interviewing,
practice in usual clinical contexts, sharing experiences and views
on a web form, and participating in a facilitator led, practice
based seminar). The box contains a full description, and figure
1⇓ describes the online structure of the programme. Novel
aspects include clinicians reflecting on their practice’s own data
on antibiotic dispensing and resistance, novel communication
skills derived from principles of motivational interviewing, and
sharing reflections on actual practice with these skills. The
intervention was flexible in that clinicians could access the
online components and try out new skills with their patients at
times that were convenient to themselves.
The control practices were not exposed to the learning
programme and provided care as usual.
Outcomes
We used data from the Prescribing Audit Reports and
Prescribing Catalogues (PARC) (www.nhsbsa.nhs.uk/
prescriptions) to determine the primary outcome for each
practice: the total number of dispensed oral antibiotic items per
1000 registered patients for the year after the intervention
practices were exposed to the STAR programme. The database
contains data for dose and the number/volume of antibiotics but
not the defined daily dose or clinical data. The version of this
database in England has been successfully used for assessing
effects of large scale interventions for reductions in antibiotic
prescribing.50 If two antibiotics were prescribed for the same
person at the same consultation, this would be registered as two
items.
Our secondary outcomes were hospital admission rates, practice
reconsultation rates, and costs.We examined hospital admission
rates for possible respiratory tract infections and their
complications per 1000 registered patients for the year after the
intervention practices were exposed to the programme. We
chose these infections because they are the most common
indication for prescribing unnecessary antibiotics in primary
care. We used routinely collected data from the Patient Episode
Database for Wales (PEDW), which records inpatient/day case
care for Welsh residents treated in an NHS hospital anywhere
in the UK (www.hsw.wales.nhs.uk/page.cfm?orgid=166&
pid=4262).
A single admission to hospital for a complication was deemed
to have occurred if a patient had been admitted to hospital for
a possible respiratory tract infection or complication. If a patient
was admitted more than once, and the gap between admissions
was 30 days or more, this was considered to be a separate
complication episode.
In patients with respiratory tract infections, we identified
practice reconsultation rates using diagnostic READ codes
(www.connectingforhealth.nhs.uk/systemsandservices/data/
uktc/readcodes) recorded by the general practitioner over seven
days, 14 days, and 31 days after an initial consultation. These
data were collected from the electronic records of a subsample
of 37 general practices (20 intervention and 17 control). We
selected practices for this subsample on the basis of the computer
software systems they used for their clinical records based on
ease of extraction and resource required (Vision (www.nvug.
org/index.html), Ganymede (www.isofthealth.com/en-GB/
Solutions/UK%20Primary%20Care/Ganymede.aspx).
To assess costs, we prospectively recorded all resources used
in preparation for STAR training in relevant units, multiplied
by appropriate unit costs,51 and apportioned equally across
intervention practices. Seminars were assumed to last for 1.5
hours and were delivered at a flat fee per seminar of £500 (€597,
$780) plus travel costs.
Learning times at seminars and on line were valued at relevant
unit costs. It was assumed that all log-on time was during
working hours, as would be the case if STAR were rolled out
across healthcare systems. Prices of antibiotics dispensed were
from the British National Formulary.52 Costing was from a
health service perspective and all costs are in 2009 prices. As
the follow-up period for costs and effects apart from resistance
was one year, discounting was not applied.
Data on antibiotic dispensing, hospital admissions, and
reconsultations were collected through routine administrative
systems that were not influenced by the STAR study research
process.
Statistical analysis
Sample size calculation
The standard deviation between practices of the changes within
practices over successive years in total dispensed antibiotic rates
per 1000 patients was 70 items per 1000 patients in Wales. To
detect a possible difference of 10% (73 dispensed oral antibiotic
items per 1000 patients) in the change in total oral antibiotic
dispensing rate per year between intervention and control
practices, with 90% power, we required 21 practices per group.
Increasing this to over 30 practices per group, however, allowed
the study to detect a difference of 8% in antibiotic dispensing
with 90% power and gave more power for analysis of secondary
outcomes.
Main analyses
The main analysis was intention to treat and compared the two
groups’ annual rates of total oral antibiotic dispensing for all
causes per 1000 practice patients within practices in the year
after the intervention, by using analysis of covariance with the
previous year’s prescribing as a covariate. Because the
distribution of rates was positively skewed, these were log
transformed to produce approximately normally distributed
data, enabling us to calculate confidence intervals for the ratios
of dispensing rates between the two groups rather than the
differences. The assumption of constant variance was not
satisfied as the list sizes varied across practices from less than
2000 to nearly 17 000 and the precision of the rate varied
accordingly. To account for this, we weighted the data using
the log of the list sizes. The same methods were applied to
antibiotic costs.
The follow-up period started for each practice in the intervention
group from the month after their practice based seminar
(betweenMay and October 2007) and continued for 12 months.
We chose a control practice at random for each practice in the
intervention group and assigned the same year long baseline
and follow-up period.
We similarly compared secondary outcomes of average hospital
admission rates for specified complications between the two
groups for the whole year. Reconsultation rates were compared
with Mann-Whitney U tests as the data were not normally
distributed. We calculated the median difference in
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Detailed description of the study intervention
The structure and online content of the STAR educational programme can be viewed at www.stemmingthetide.org. The entire learning
programme consists of seven parts.
• Part 1 (on line): Clinicians were asked to make judgments about how they might handle four case scenarios (fig 2⇓). They also reflected
on the problem of antibiotic resistance and their decisions regarding antibiotic prescribing and were provided with up to date summaries
of research evidence and guidelines as well as videos giving a range of opinions (viewpoints from experts, patients, and clinicians)
• Part 2 (on line): Clinicians reflected on their decision whether or not to prescribe antibiotics for four actual patients they had managed
and uploaded summaries of the cases onto the STAR website. The researchers did not limit the type of infections. Other clinicians
taking part in the study could also see these summaries
• Part 3 (face to face): Guided by the principles of information exchange derived frommotivational interviewing,46 a facilitator in a practice
based seminar presented, and invited interpretation of, seven year trends for antibiotic dispensing and resistance trends at all Wales,
local area level, and the actual practice (fig 3⇓). Resistance rates were based on coliforms in urine samples routinely submitted to
laboratories from general practice for microbiological analysis (resistance in urinary tract infection is associated with prescribing for
other infections and large numbers of urine samples are routinely sent for microbiological analysis).14 The aim was to encourage
prescribers to interpret data from their own practice and to consider appropriate responses
• Part 4 (on line): Clinicians repeated questions on the four initial online case scenarios and attitude questions from part 1. They were
able to access responses of other participating clinicians and compare them with their own. Attention then turned to consulting skills.35 47
These included: “Lifting the Lid”—identifying the main concerns and expectations of the patient; “Information Exchange”—using a
strategy from motivational interviewing to share information about the pros and cons of antibiotic use, prognosis, treatment, and
reconsulting; and “Wrap-Up”—acknowledging the patient’s concerns, summarising the medical situation, clarifying reasons to reconsult,
and checking back with the patient.47 48 Four video scenarios demonstrated these skills, and interactive exercises invited clinicians to
identify evidence of “good practice in an antibiotic consultation” by clicking on option boxes as videos unfolded. Perspectives from
patients, clinicians, and expert colleagues on the consultations were linked to supporting research evidence and guidelines
• Part 5 (clinical practice with reflection): In keeping with principles of context bound learning,49 clinicians described three of their own
consultations in which they used the new consultation skills. These reflections were recorded on line and securely shared with other
clinicians on the programme
• Part 6 (online): An ongoing active web forum provided updates on emerging relevant scientific evidence and allowed educators in the
STAR study team to respond to queries, feedback, and comments. Clinicians were able to add to existing threads and start new topics
on the forum
• Part 7 (on line): A booster module, six to eight months after completion of the initial training, reminded clinicians of the previously
outlined consultation skills and showed a video of a consultation for a common infection where they were asked to identify key strategies
that were used. Clinicians were sent a snapshot of their practice’s antibiotic dispensing from two recent winter months compared with
the rates of corresponding months for the year before they began the programme.
reconsultation rates between intervention and control groups
with 95% confidence intervals constructed with bootstrapping
methods.
Results
We wrote to 212 of 499 general practices in Wales about the
study. Forty five practices were ineligible because we could not
obtain certain routine data for them. We had just contacted 242
practices, chosen at random from the 499, about a different
study and so also considered them ineligible for this study. Of
the 212 practices wewrote to, 102 expressed an interest in taking
part. After discussion, 70 agreed to participate. One practice
subsequently withdrew before randomisation, and one was
considered ineligible because only one out of seven clinicians
agreed to participate, leaving 68 practices serving about 480
000 patients that were randomised to either intervention or
control (34 each) (fig 4⇓). The previous year’s antibiotic
dispensing rate for the 68 practices that were randomised was
about 15% lower than the Welsh average.
Two practices, one in each group, withdrew after randomisation
but were included in the intention to treat analyses. In the
intervention practices that agreed to participate, 127 of the 139
clinicians completed the programme. Of the 124 clinicians in
the control practices, 117 participated (fig 4). Table 1⇓ describes
the demographic features of the practices in each randomisation
group.
Uptake of the intervention
Intervention clinicians had to complete each online learning
component before the software would allow them to access the
next. All but one completed the four parts of the online training
and uploaded descriptions of consultations for the portfolio
tasks. Only 10 clinicians did not attend the practice based
seminars. Seventy six completed the optional booster session
at six months. Eleven clinicians entered new threads on the
online forum but there were 81 posts and 1485 viewings of these
posts and threads.
Antibiotic dispensing, admissions to hospital,
reconsultation, and costs
Antibiotic dispensing
General practices exposed to the programme reduced oral
antibiotic dispensing for their patients by 14.1 items per 1000
registered patients, while control practices increased antibiotic
dispensing by 12.1 items per 1000 registered patients. Thus, the
intervention led to a difference in 26.1 items per 1000 registered
patients per year. From the weighted analysis of covariance
model, we found a significant reduction in antibiotic dispensing
in the intervention group, after controlling for the baseline
dispensing rate (P=0.02). This represented a reduction of 4.2%
(95% confidence interval 0.6% to 7.7%) in total oral antibiotic
dispensing for all age groups and conditions in the year after
intervention (table 2⇓) in the intervention group relative to the
control group. Reductions were found for all classes of antibiotic
other than penicillinase-resistant penicillins but were largest
and significant individually for phenoxymethylpenicillins (7.3%,
0.4% to 13.7%) and macrolides (7.7%, 1.1% to 13.8%) (table
2).
We had hypothesised that the effect would be greater in those
intervention practices where two thirds or more of the clinicians
participated. The average reduction in dispensing in the
follow-up year in those practices in the intervention group in
which more than 67% of general practitioners participated was
17.7 items per 1000 registered patients per year, while in the
remainder of the intervention group dispensing actually
increased by an average of 2.6 items per 1000 registered patients
per year.
Admissions to hospital and reconsultations
There were no significant differences in admissions between
intervention and control groups. The rate of hospital episodes
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for possible respiratory tract infections and complications in
the intervention group increased by 1.9% (−8.2% to 13.2%)
relative to the control group, in the year after the intervention
(P=0.72; table 2⇓).
There were no significant differences between intervention and
control groups for reconsultation rates after an index
consultation, expressed as reconsultations per 1000 registered
patients, for respiratory tract infections (median difference
(intervention−control) −0.65 (−1.69 to 0.55) at seven days;
−1.33 (−2.12 to 0.74) at 14 days; and −2.32 (−4.76 to 1.95) at
31 days (table 3⇓).
Costs
Table 4⇓ shows the costs of delivering STAR training to 33
intervention practices. The average time clinicians spent on line
was 238 minutes. The opportunity cost of those trained (value
of time not spent on other work activities) represents the largest
cost element of the programme (£71 659). The overall mean
cost was £2923 per practice (SD £1187).
Themean annual cost of antibiotic dispensing fell in both groups
between baseline and follow-up (table 2), but the fall in
intervention practices was greater (intervention £120.76, control
£2.31 per 1000 patients). The mean antibiotic cost for the
follow-up year in the intervention group decreased by 5.5%
(−0.4% to 11.4%; P=0.07) relative to that in the control group.
Thus, the best estimate of the difference in antibiotic dispensing
costs is £118.45 per 1000 patients per year or about £830 per
year less for an average intervention practice.
Discussion
General practices exposed to the STAR educational programme
reduced their rate of dispensing oral antibiotics for all causes
by 14 items per 1000 registered patients, while control practices
increased theirs by 12 items per 1000 registered patients. Thus,
the intervention led to a difference of 26 items per 1000
registered patients a year. This represented a reduction of 4.2%
(0.6% to 7.7%) in total oral antibiotic dispensing for all age
groups and all conditions in the year after the intervention
relative to the control practices. Reductions were significant for
antibiotics commonly used for certain respiratory tract infections
(such as sore throat) in the UK (7.3% for
phenoxymethylpenicillins (penicillin V) and 7.7% for
macrolides). The intervention incorporated use of the modified
Centor criteria,53 which could explain the greater impact on
antibiotics commonly used for treating sore throats. The
reduction was greater in the practices where more than two
thirds of the general practitioners participated in the study. The
increased dispensing in the control practices could reflect
increasing antibiotic prescribing across the UK.18 19
We found no evidence that antibiotic dispensing was reduced
at the expense of increased reconsultations or complications
with common infections, although the study was not powered
to identify small changes.
The reductions in antibiotic dispensing were achieved at an
average cost of £2923 per practice (SD £1187). There was a
5.5% non-significant reduction in the cost of dispensed
antibiotics in the intervention group, amounting to £118.45 per
1000 patients per year. If this was the true value and the benefit
of the intervention was maintained over time, then the
investment in the intervention would be recouped within 3.5
years.
Strengths and limitations of the study
We showed that a complex flexible blended learning approach
to continuing education for clinicians is effective in reducing
all cause antibiotic prescribing, and we evaluated the impact on
the costs of antibiotic dispensing.23 32
Some primary care clinicians consider antibiotic resistance to
be a hospital based problem, unaffected by their own prescribing
behaviour.38 39 The intervention included discussion of practice
specific antibiotic dispensing and resistance data, as well as a
report showing an association between reductions in practice
based dispensing and local levels of resistance, which has not
been done before.14
Increased use of “delayed prescribing” in the UK makes
dispensed antibiotics a better outcome measure for this study
than prescribed antibiotics as it is a better proxy for antibiotics
actually consumed.
The outcome was antibiotic dispensing for the whole practice
population regardless of how many practitioners in the practice
were exposed to the intervention. Our pragmatic approachmeant
that we used practices in which not all clinicians participated.
This enhances the applicability of findings as not all clinicians
are likely to participate should the intervention be rolled out.
Studies that analyse data only from participating clinicians are
likely to overestimate potential practice effects.
Selection of patients and consent from individual patients was
not required, and outcomes were collected for the whole practice
population irrespective of diagnosis by using routinely collected
data. This eliminated the problem of limiting the primary
outcome to only those patients who participating clinicians were
able to recruit, rather than determining the practice level effect.54
Furthermore, diagnostic codes can be selected to justify
decisions regarding antibiotic prescribing (diagnostic drift),
which can make judgments of appropriate prescribing difficult.
It is potentially much easier to show changes for small numbers
of individually recruited patients over a short period of time
than for all cause prescribing for a whole practice population
over a whole year.36 37 55 Other studies have included only three
winter months in their outcomes.50 This could explain why
reductions seen in our study are less dramatic than those seen
in efficacy studies.
Few, if any, studies on this issue have evaluated effects of
interventions on complications and repeat consultations.23 32Our
limited analyses did not identify a significant effect on admission
to hospital for respiratory tract infections or complications.
These are relatively rare, however, and the study was not
powered to detect small differences. We also examined effects
on reconsultations for selected common infections in a subset
of practices and found no important differences; in fact the
observed rate was lower in the intervention group.
We conducted process evaluation interviewswith 31 purposively
sampled clinicians in the intervention practices.56Most reported
increased awareness of antibiotic resistance, greater self
confidence in reducing antibiotic prescribing, and at least some
change in consultation style and antibiotic prescribing behaviour.
Reported practice changes included adopting a practice-wide
policy of reducing antibiotic prescription. Many reported
increased insight into patients’ expectations, ultimately
contributing to improved clinician-patient rapport. The
components of the intervention reported as having the greatest
influence on changing clinician behaviour were the up to date
resources for evidence from research, simple and effective
communication skills presented in online videos, and
presentation of the practice’s own antibiotic dispensing rates
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combined with practice specific and local area data on
resistance.56
As we do not have reliable patient denominator data for each
practitioner (numbers of patients registered or seen, and the
diagnosis), we could not determine which practitioners
responded most to the intervention and for which patients and
diagnoses the greatest reductions were achieved. The lack of
diagnostic data means that we were able to consider only
reductions in total oral antibiotics and not the effect on
inappropriate antibiotic prescribing. Also, we do not know if
hospital admissions were increased among those who might
otherwise have been prescribed antibiotics in primary care. We
were unable to provide a meaningful comparison of the length
of consultations before and after the intervention.
While almost all intervention clinicians completed the different
components of the intervention, only 11 entered new threads
on the web forum (part 6). There were, however, 81posts
(comments on new threads and responses to comments) and
over 1400 viewings of the threads and subsequent posts.
Comparison with other studies
National public awareness campaigns in the UK around the time
this study was done were not associated with any reduction in
all cause antibiotic prescribing in the community or changes in
the public’s reported behaviour and beliefs.20 57A regional mass
media campaign in northeast England over two years included
leaflets, posters on buses, local newspaper, radio, and TV
coverage, and professional education and prescribing support.50
They found 21.7 fewer items were prescribed per 1000
population for the intervention population over the winter
months compared with our finding of 26 fewer items for a whole
year.
A systematic review of interventions to reduce unnecessary
antibiotic prescribing included 43 studies and found that most
(38) focused only on acute respiratory infections.23Most of these
studies evaluated the effect of only one or two types of approach,
in contrast with our intervention, which explored both the “how”
and “why” of change in a flexible learning format, using
practice-specific prescribing and resistance data, information
about guidelines, reflections on practice based experience,
academic outreach, and a web forum. None of the other studies
provided feedback to practices about their own antibiotic
dispensing rates combined with practice specific resistance data.
Our intervention combines all of the elements identified as
promising or effective and provides cost data.23 32 Few of the
studies included in systematic reviews provided longer term
follow-up data. Effect sizes vary considerably in the studies
included in the reviews, which is expected given the
heterogeneous study designs, interventions, and outcome
measures.23 32 This also makes meaningful comparisons about
the relative effectiveness of studies difficult.
Conclusions
The STAR educational programme led to reductions in oral
antibiotic dispensing for all causes over the subsequent year
with no significant changes in admissions to hospital,
reconsultations, or costs. These results will be of interest to
those concerned with antimicrobial stewardship and in the
broader project of enhancing the quality of prescribing and
changing clinicians’ behaviour through innovation in continuing
medical education.
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Tables
Table 1| Summary of demographic features of practices undergoing educational programme aimed at reducing antibiotic prescribing in
primary care. Figures are numbers (percentages) unless stated otherwise
ControlIntervention
3434Practices*
155159Clinicians in practices*
124139Consenting clinicians*
70507053Mean list size (at baseline)*
115127Participating clinicians†
76 (66)77 (61)Male clinicians†
Age (years)†:
1 (1)7 (6)25-30
24 (21)35 (28)31-40
56 (49)48 (38)41-50
31 (27)35 (28)51-60
3 (3)2 (2)≥61
*Based on data for all randomised practices.
†Based on data for participating clinicians (either completing online training for intervention group or clinicians in control group for whom data were available).
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Table 2| Summary results of antibiotic dispensing (primary outcome), dispensing cost per practice, and rate of admission to hospital in
practices undergoing educational programme aimed at reducing antibiotic prescribing in primary care
P value
% reduction in intervention
group relative to control
group* (95% CI)
Mean at follow-upMean at baseline
Outcome InterventionControlInterventionControl
0.024.2 (0.6 to 7.7)664.0681.1678.1669.0All antimicrobials†
Broad spectrum penicillins†:
0.144.7 (−1.6 to 10.7)238.9249.6252.6254.3All†
0.134.7 (−1.5 to 10.6)203.9211.5215.8215.5Amoxicillin†
0.237.3 (−5.1 to 7.3)33.736.334.636.0Co-amoxiclav†
0.047.3 (0.4 to 13.7)49.547.353.345.8Phenoxymethylpenicillin†
0.652.3 (−8.0 to 11.6)49.555.650.053.7Cephalosporins†
0.027.7 (1.1 to 13.8)73.776.776.473.9Macrolides†
0.148.3 (−2.9 to 18.5)20.823.720.922.0Quinolones†
0.43−3.4 (−12.3 to 4.8)76.267.576.367.8Penicillinase-resistant
penicillins†
0.244.3 (−2.4 to 8.9)66.670.663.265.5Trimethoprim†
0.224.7 (−1.5 to 10.6)58.560.357.357.0Tetracyclines†
0.72−1.9 (−13.2 to 8.2)7.58.07.78.7Hospital admissions‡
0.075.5 (−0.4 to 11.4)2078.92252.32199.72254.6Dispensing cost/practice (£)
*Difference between means in intervention group and control group as percentage of mean in control group.
†Annual No of dispensed units for oral antibiotics per 1000 registered patients.
‡Annual No of hospital episodes for possible respiratory tract infections and complications of common infections per 1000 registered patients.
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Table 3| Re-consultation rates for respiratory tract infections within seven, 14, and 31 days in practices undergoing educational programme
aimed at reducing antibiotic prescribing in primary care
P value§Median difference (95% CI‡)
Median (IQR)
Re-consultation rate* Control (n=17)†Intervention (n=20)†
0.446−0.65 (−1.69 to 0.55)3.35 (2.16-4.31)2.66 (1.88-4.25)Within 7 days
0.411−1.33 (−2.12 to 0.74)6.43 (4.04-7.84)5.10 (4.70-7.92)Within 14 days
0.503−2.32 (−4.76 to 1.95)11.38 (7.39-14.05)9.06 (7.53-12.62)Within 31 days
IQR=interquartile range.
*Median No of individuals who reconsulted for respiratory tract infection per 1000 registered patients.
†Values in each group refer to subset of intervention practices for which data on reconsultation were available.
‡Computed with bootstrapping methods.
§From Mann-Whitney U test.
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Table 4| Costs of STAR educational programme aimed at reducing antibiotic prescribing in primary care
Cost (£)Unit cost (£)UnitsActivity
Administration
4320Various*350.6 hoursAdministration
434Various†VariousMaterials and postage
4754——Total
Seminar preparation
1598Various*45.5 hoursProject staff preparation time
364Various*14 hoursTraining trainers
574115*5 daysPreparing practice level data (Health Solution Wales staff)
2536——Total‡
Seminar delivery
16 50050033 seminarsTrainers’ fee
1010—Claim formsTrainers’ travel/expenses
17 510——Total‡
Cost to practices
19 656104§126 @ 1.5 hoursPhysician time (seminar)
8428¶2 @ 1.5 hoursNurse practitioner time (seminar)
51 626104§496.40 hoursPhysician time (logged on)
29428¶10.51 hoursNurse practitioner time (logged on)
71 659——Total cost of trainee time‡
96 460——Total cost of STAR training (33 practices)‡
2923 (1187)——Mean (SD) cost per practice
*Staff salaries uplifted by 22.5% to include on costs (national insurance, etc).
†University admin dept/Royal mail.
‡Totals rounded.
§ Per hour GMS activity, with qualifications excluding direct care staff costs.51
¶Per hour with qualifications (no client contact).51
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Figures
Fig 1 Screenshot of the whole programme
Fig 2 Screenshot of the “What would you do?” section
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Fig 3 Example of data fed back during practice based seminars: “Your practices’ antibiotic prescribing and resistance in
urine samples compared to your Local Health Board (LHB) and all Wales, averaged over seven years”
Fig 4 Participant flow diagram
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